Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sivalingam, S. Mowatt, K. Hall, I. Chakravorty, K. Farrington (Stevenage, United Kingdom). Do nocturnal apnoeas contribute to increased cardiovascular risk in end stage renal disease patients?. Eur Respir J 2008; 32: Suppl. 52, 795

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of obstructive sleep apnea and HLA frequency in patients with end stage renal disease Source: Eur Respir J 2006; 28: Suppl. 50, 647s Year: 2006 Renal function impairment and prediction of sleep apnea in patients with high cardiovascular risk Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea Source: Eur Respir J 2001; 17: 573-574 Year: 2001 OSA as a cause of cardiovascular disease, including heart failure Source: ERS Conference Year: 2015 Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Increased obstructive sleep apnoea (OSA) severity is associated with increased cardiovascular risk, calculated using the RISKSCORE algorithm, and reduced left ventricular function in minimally symptomatic patients Source: Annual Congress 2010 - News from RCT (randomised controlled trials) and epidemiology in sleep apnoea Year: 2010 Mean platelet volume in obstructive sleep apnea patients. Another link to cardiovascular disease? Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 The relationship between some oxidative stress markers and metabolic cardiovascular risk factors in the blood of different stage obstructive sleep apnea persons Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Early cardiovascular disease markers in "healthy" OSA patients are correlated with sympathetic activity Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011 In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 The cardiovascular  comorbidity and the risk of stroke by means of CHADS2- VASc scale  in patients with chronic obstructive pulmonary disease. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea Year: 2009